[奥美拉唑对壁细胞H⁺/K⁺-ATP酶的抑制作用：胃酸抑制的新原理] - Suppr

Suppr

超能文献

[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].

作者信息

Lamers C B

出版信息

Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82.

PMID:2986019

Abstract

摘要

相似文献

[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].

Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82.

Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.

Annu Rev Med. 1986;37:97-105. doi: 10.1146/annurev.me.37.020186.000525.

The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Scand J Gastroenterol Suppl. 1985;108:37-51.

The gastric H+,K+-ATPase: the site of action of omeprazole.

Scand J Gastroenterol Suppl. 1989;166:3-11.

[Substituted benzimidazole, inhibiting substance of K+/H+ ATPase of parietal cells--a new principle in the treatment of peptic ulcer].

Internist (Berl). 1983 Dec;24(12):680-3.

Mechanism of action of omeprazole.

Scand J Gastroenterol Suppl. 1986;118:11-7. doi: 10.3109/00365528609090881.

[Are proton pump inhibitors safe?].

Internist (Berl). 1994 Dec;35(12):1137-46.

Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles.

Br J Pharmacol. 1984 Jul;82(3):651-7. doi: 10.1111/j.1476-5381.1984.tb10803.x.

Antisecretagogues and parietal cells.

Agents Actions. 1984 Apr;14(3-4):319-24. doi: 10.1007/BF01973820.

Relationship of omeprazole-induced hypergastrinemia to gastric pH.

Surgery. 1986 Aug;100(2):175-80.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].

作者信息

Lamers C B

出版信息

Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82.

PMID:2986019

Abstract

摘要

相似文献

[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].

Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82.

Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.

Annu Rev Med. 1986;37:97-105. doi: 10.1146/annurev.me.37.020186.000525.

The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Scand J Gastroenterol Suppl. 1985;108:37-51.

The gastric H+,K+-ATPase: the site of action of omeprazole.

Scand J Gastroenterol Suppl. 1989;166:3-11.

[Substituted benzimidazole, inhibiting substance of K+/H+ ATPase of parietal cells--a new principle in the treatment of peptic ulcer].

Internist (Berl). 1983 Dec;24(12):680-3.

Mechanism of action of omeprazole.

Scand J Gastroenterol Suppl. 1986;118:11-7. doi: 10.3109/00365528609090881.

[Are proton pump inhibitors safe?].

Internist (Berl). 1994 Dec;35(12):1137-46.

Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles.

Br J Pharmacol. 1984 Jul;82(3):651-7. doi: 10.1111/j.1476-5381.1984.tb10803.x.

Antisecretagogues and parietal cells.

Agents Actions. 1984 Apr;14(3-4):319-24. doi: 10.1007/BF01973820.

Relationship of omeprazole-induced hypergastrinemia to gastric pH.

Surgery. 1986 Aug;100(2):175-80.